From a morphological point of view, in the presence of mutated SF3B1, the evidence of anemia, optionally associated with erythroid dysplasia in the bone marrow, definitely supports the diagnosis of MDS/MPN-T. Here, SF3B1 is linked to myeloproliferative neoplasm.